Heart Transplantation clinical trials

Explore recruiting heart transplantation clinical trials.

Recruiting heart transplantation studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Heart Transplantation trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Cytomegalovirus Prophylaxis with Letermovir in Heart Transplant Recipients: A Non-randomized Cohort Pilot Study

Slovenia

Therapeutic exploratory (Phase II) EU CTIS Study details

Platelet function testing in outpatients after heart transplantation on aspirin therapy

Austria

Therapeutic use (Phase IV) EU CTIS Study details

A prospective randomized single blind multicenter phase II study of organ perfusion with Custodiol-N compared with Custodiol in heart transplantation in children (CL-N-HTX-Paed-II/10/20)

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Hydralazine-ISDN in Patients With Chronic Heart Failure - Hydralazine Heart Failure Trial (H-HeFT) Metformin in Patients with Chronic Heart Failure and Diabetes or Insulin Resistance - Metformin Heart Failure Trial (Met-HeFT) A randomized, 2 x 2 factorial designed, double-blind, placebo controlled study (DANHEART).

Denmark

Therapeutic confirmatory (Phase III) EU CTIS Study details

Pulse corticosteroids or/and Immunoglobulins to treat fulminant Myocarditis: a double-blind randomized controlled adaptive trial (The CORIUM study)

France

Therapeutic exploratory (Phase II) EU CTIS Study details

(21466) A multicenter, randomized, double-blind, placebo-controlled, Phase 3 study to investigate the efficacy, safety, and PK/ PD of finerenone, in addition to standard-of-care, in pediatric patients, 6 months to < 18 years of age, with heart failure (HF) and left ventricular systolic dysfunction (LVSD)

Czechia, Poland, Portugal, Austria, Finland, Greece +7 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Heart Transplantation trials by city

Heart Transplantation in Toronto Heart Transplantation in Vancouver Heart Transplantation in Montreal Heart Transplantation in Calgary Heart Transplantation in Edmonton Heart Transplantation in Ottawa Heart Transplantation in Winnipeg Heart Transplantation in Quebec City Heart Transplantation in Hamilton Heart Transplantation in Kitchener Heart Transplantation in London Heart Transplantation in Halifax Heart Transplantation in New York Heart Transplantation in Los Angeles Heart Transplantation in Chicago Heart Transplantation in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease